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Abstract
HIV-1 envelope (Env) glycoprotein is a trimer of heterodimer of gp120 and gp41, and derives from a trimeric glycoprotein
precursor, gp160. Gp120 contains five conserved regions that are interspersed with 5 variable loop regions (V1–V5). Env
variations in variable loop length and amino acid composition may associate with virus pathogenesis, virus sensitivity to
neutralizing antibodies (nAbs) and disease progression. To investigate the role of each variable loop in Env function, we
generated a panel of JRFL gp160 loop deletion mutants and examined the effects of each loop deletion on Env expression,
Env cell surface display and Env-mediated virus entry into permissive cells. We found that deletion of V1 and V2 (DV1V2), or
loop D (DlpD) abolished virus entry, the same effect as deletion of V3 (DV3), while deletion of V3 crown (DV3C) significantly
enhanced virus assembly and entry. We further found that deletion of V4 (DV4) or V5 (DV5), or replacement of V4 or V5 with
flexible linkers of the same lengths knocked out the receptor and coreceptor binding sites in gp120, but significantly
enhanced the exposure of the N-trimer structure and the membrane proximal external region (MPER) in gp41. Although
deletion of V4 or V5 did not affect Env expression, they negatively affected Env cell surface display, leading to the failure in
virus assembly and subsequent entry. Taken together, we found that Env variable loops were indispensable for Env
structural integrity and virus entry. Our findings may have implications for development of HIV-1 vaccine immunogens and
therapeutics.
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Introduction
HIV-1 envelope glycoprotein (Env) is a trimer of heterodimer of
the mature surface glycoprotein gp120 and the transmembrane
glycoprotein gp41. Env trimer mediates virus entry into permissive
cells upon binding to the receptor (CD4) and coreceptor (CCR5 or
CXCR4). Env gp120 contains five variable loops (V1–5) that are
interspersed with five sequence conserved regions (C1–5). Despite
sequence and length variations, Env variable loops are important
determinants or indicators for coreceptor tropism, virus sensitivity
to neutralization by antibodies, virus pathogenesis, and disease
progression [1,2,3,4,5,6,7,8,9]. It is well studied that V3 is the
primary determinant of viral coreceptor usage although mutations
outside the V3 have impact on coreceptor tropism of subtype B
viruses [3]. V1V2 region may influence coreceptor binding and
participate in shielding of neutralization-sensitive regions of the
Env. V1V2 length and potential N-linked glycosylation sites
(PNGS) were found to increase significantly through chronic
infection before declining in late-stage infection [1], and an
increase in the V1V2 length and/or the number of PNGS in the
V1V2 region directly contributed to viral resistance to HIV-
specific neutralizing antibodies (nAbs) [4,10]. Important structural
motifs formed by the C3 and V4 regions and the epitopes within
the motifs were also found to be major targets of the early
autologous neutralizing response in HIV-1 subtype C infection [7].
Extensive intra-patient V4 variability in length and number of
PNGS has also been observed in clade B, G, and CRF02 isolates
during early infection [2]. In addition, some variable loops
constitute neutralizing determinants recognized by several known
broadly neutralizing HIV-1 human monoclonal antibodies
(bnmAbs). For example, bnmAb VRC01 binds to an epitope
formed by the CD4 binding site (CD4bs), V5 and loop D (lpD)
[11], and bnmAbs PG9/16, CH04 and PGT145 are V1/V2-
directed antibodies [12], while a short b-strand segment of the V3
loop is involved in binding of PGT127 and 128 to Env trimer [13].
These observations suggest potentially important roles of variable
loops in Env-mediated virus entry and virus pathogenesis.
However, how changes in these loops affect Env function are
not well studied.
In this study, we generated a series of loop deletion or
replacement mutants of JRFL gp160, and investigated the effects
of each loop deletion or replacement on Env expression, Env cell
surface display, and virus assembly and subsequent virus entry into
permissive cells. In addition to the five variable loops, we also
investigated the importance of two other loops, the CD4 binding
loop (CD4bl) and lpD, for Env-mediated viral function. We
further investigated if deletion of Env cytoplasmic tail (CT) can
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rescue the defects in Env expression and function caused by
variable loop deletions.
Materials and Methods
Cells, Plasmids, Medium, Antibiotics, and Antibodies
93 T cells were purchased from ATCC. TZM-bl cell line was
obtained from the NIH AIDS Research and Reference Reagent
Program (ARRRP). The pSVIII-JRFL gp160 wild type (WT) and
pcTAT plasmids were kindly provided by Yuxing Li, Richard
Wyatt and Joseph Sodroski [14]. DMEM medium, fetal bovine
serum (FBS) and penicillin-streptomycin (pen-strep) were pur-
chased from Gibco. Purified gp120-specific polyclonal Abs D7324
were purchased from Aalto BioReagents. IgG1s b12 and 2G12
were obtained from ARRRP. IgG1 VRC01 was kindly provided
by Xueling Wu and John Mascola. The rest of HIV-1 mAbs were
produced in our laboratory by transient transfection of 293F cells
(Invitrogen) followed by Protein A (GE Healthcare) affinity
purification.
Construction of Loop Deletion Mutants
Full-length JRFL gp160 gene in pSVIII was used as a template
for generation of various loop deletion or replacement mutants,
including single loop deletion of V2 (DV2), V3 (DV3), V4 (DV4),
V5 (DV5), loop D (DlpD), CD4 binding loop (DCD4bl), and
deletion of V2 crown (DV2C) and V3 crown (DV3C), and double
loop deletion of V1 and V2 (DV1V2), and loop D and V5
(DlpDDV5), and replacement of V4 (DV4fl) and V5 (DV5fl) with
flexible linkers of the same lengths (Table 1). A panel of primers
were designed and synthesized for amplification of different
fragments of JRFL gp160 gene and for replacement of each loop
with either a short flexible linker or a flexible linker of the same
length as the original loop (in the case of V4 and V5) (Table 1 and
2). Primer pSV3for was paired with each anti-sense primer to
amplify the upstream fragments of the Env, and primer pSV3rev
was paired with each sense primer for amplification of the
corresponding downstream fragments using the following PCR
program: an initial denaturation at 94uC for 5 min, followed by 10
cycles of 95uC for 20 s, 50uC for 30 s and 72uC for 90 s, and 20
cycles of 95uC for 20 s, 55uC for 30 s and 72uC for 90 s, and a
final extension at 72uC for 10 min. The upstream and the
corresponding downstream fragments for each mutant were
assembled by splice overlap extension (SOE) as follow: an initial
denaturation at 94uC for 5 min, followed by 5 cycles of 95uC for
20 s, 55uC for 30 s and 72uC for 90 s. The assembled full-length
gp160 loop deletion mutant genes were then amplified by PCR
using pSV3for and pSV3rev as a pair of primers and the following
PCR program: 20 cycles of 95uC for 20 s, 55uC for 30 s and 72uC
for 3 min, and a final extension at 72uC for 10 min. All PCR
products were gel-purified using QIAquick gel extraction kit
(Qiagen), digested with KpnI and BamHI, and ligated to pSV3
plasmid digested with the same restriction enzymes. Ligation
products were used to transform TG1 electroporation competent
cells. Each loop deletion or replacement mutant was confirmed by
DNA sequencing.
Transient Transfection of 293 T Cells and Flow Cytometry
The day before transfection, 293 T cells were seeded in DMEM
growth medium (DMEM containing 10% FBS and 1% pen-strep).
70–80% confluent 293 T cells were co-transfected with pSVIII
expression plasmid containing JRFL wild type (WT) gene or its
loop deletion or replacement mutants, and pcTAT using PEI as a
transfection reagent in DMEM medium containing 10% FBS. 4–
6 h post transfection, the medium was changed to DMEM growth
medium. 48 h post transfection, 293 T cells were harvested,
washed with FACS buffer (PBS+5% FBS) and stained with IgG1
2G12, or VRC01, or b12 as a primary antibody at 4uC for 1 h.
Following washing three times with FACS buffer, cells were
incubated with phycoerythrin (PE) conjugated to anti-human Fc
(Sigma) (1:200) at 4uC for 45 min. Cells were then washed again
three times with FACS buffer and analyzed on a BD flow
cytometer. The results were analyzed by FlowJo software.
Generation of Env-pseudotyped Viruses
Env-pseudotyped viruses were assembled by co-transfection of
293 T cells with Env plasmid containing JRFL Env WT gene or its
loop deletion or replacement mutants with or without the CT, and
HIV-1 backbone plasmid pNL4-3 containing a luciferase reporter
gene and HIV-1 structural genes. 48 h post transfection, the
culture supernatants containing assembled pseudovirus were
harvested and stored at 280uC, or directly used in virus titration
by capture ELISA and subsequent virus entry assay.
Pseudovirus Entry Assay
Crude preparation of pseudovirus in culture supernatant was 3-
fold serially diluted in DMEM growth medium and 100 ml of each
dilution in triplicate were placed in 96-well flat-bottom cell culture
plates. 100 ml of TZM-bl cell suspension in DMEM growth
medium containing DEAE-Dextran (25 mg/ml) were dispensed to
the wells to a final cell density of 10,000 cells per well and a final
concentration of DEAE-Dextran of 10 mg/ml. The plates were
then incubated at 37uC with 5% CO2 for 48 h. Cells were washed
with PBS once and lysed with 60 ml per well lysis buffer by
incubating at RT for 30 min followed by addition of 25 ml of
luciferin (Promega). Luminescence readings (RU) were determined
by PE Victor3 luminometer. Relative pseudovirus entered into the
cells was calculated as follow: (RUsample-RUblank)/(RUWT-RU-
blank)6100.
Capture ELISA
250 ng per well of D7324 in PBS were coated on high-binding
96-well half-well microplates by incubating the plates at 4uC
overnight. Following blocking the wells with 2.5% skim milk in
PBS (MPBS), 3-fold serially diluted whole cell lysate or
pseudovirus-containing culture supernatant in lysis buffer (2%
Triton X-100 from Sigma in PBS) were added to the ELISA
plates. Captured JRFL gp160s were detected by using IgG1 2G12
as a primary antibody and HRP conjugated to anti-human F(ab’)2
(1: 2,500) as a secondary antibody, and ABTS (Roche) as
substrate. The optical density at 405 nm (OD405nm) was
determined after color development at RT for 20 min. A similar
capture ELISA set-up was used to determine structural integrity of
loop deleted or replaced JRFL gp160 by measuring the binding of
a panel of HIV-1-specific mAbs to each loop deleted or replaced
Env mutant and WT captured on microplates. HIV-1-specific
mAbs include CD4bs mAbs VRC01 and b12, CD4-induced
(CD4i) mAbs X5 and 17b, and gp41-specific mAbs m47 (N-
trimer-specific, unpublished), 2F5 and 4E10. Glycan-specific mAb
2G12 was included in the assay to measure each loop deleted or
replaced Env mutant expressed in 293 T cells. A standard curve
used for data calibration was generated using recombinant
JRFLgp120 as antigen and 2G12 as a primary antibody in the
same capture ELISA.
Immunohistochemistry (IHC) Assay
48 h post transfection, 293 T cells were fixed using 4%
paraformaldehyde fixative solution by incubation at RT for
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Table 1. JRFL gp160 loop deletion or replacement mutants.
JRFL Env loops Original loop sequence
Replacing linker sequence and designated name of
the construct
V1V2 VNATNTTNDSEGTMERGEIKNCSFNITTSIRDEVQKEYALFYKLDVVPIDNNNTSYRL GSGSG (DV1V2)
V2 NITTSIRDEVQKEYALFYKLDVVPIDNNNTSYRL GSGSG (DV2)
V2 crown FYKLD AAAAA (DV2C)
loop D NFTNNAKT AAAA (DlpD)
V3 NTRKSIHIGPGRAFYTTGEIIG GSGSG (DV3)
V3 crown GPGR AAAA (DV3C)
CD4bl SSGGDPEIVMH GSGSG (DCD4bl)
V4 NSTQLFNSTWNNNTEGSNNTEGNTITLP GSGSG (DV4); or GGGGSGGGGSGGGGSGSGSG (DV4fl)
V5 INENGTEIFR GSGSG (DV5); or GGGGSGSGSG (DV5fl)
The amino acid (AA) sequences of the original loops and flexible linkers for replacement are shown. V2 and V3 crown sequences are underlined. CD4bl: CD4 binding
loop. DV4fl and DV5fl: V4 and V5 loops replaced with flexible linkers of the same lengths. Designated names of resultant constructs are indicted in parentheses.
doi:10.1371/journal.pone.0069789.t001
Table 2. Primers used to construct JRFL gp160 loop deletion mutants.
Primer Name Primer Sequence (59 to 39) Use
pSV3for ACCATGCTCCTTGGGATGTTGATG annealing to plasmid
pSVIII
pSV3rev TCTCAAGCGGTGGTAGCTGAAGAG annealing to plasmid
pSVIII
delLpDF GACGCTGCAGCAGCTATAATAGTACAGCTGAAAGAATC generating DlpD
delLpDR AGCTGCTGCAGCGTCAGATCTAATTACTACCTC
Delv1v2F GGTAGCGGATCAGGTATAAGTTGTGACACCTCAGTC generating DV1V2
Delv1v2R ACCTGATCCGCTACCATCCTTGCAATTTAAAGTAAC
V2crownF GCTGCTGCAGCTGCTGTAGTACCAATAGATAATAATAATACC generating DV2C
V2crownR AGCAGCTGCAGCAGCAAGAGCATATTCTTTCTGCAC
delfullV2F GGTTCAGGATCTGGCATAAGTTGTGACACCTCAGTC generating DV2
delfullV2R GCCAGATCCTGAACCGAAAGAGCAGTTTTTTATTTCTC
V3crownF TAGCAGCAGCTGCAGCATTTTATACTACAGGAG generating DV3C
V3crownR CTGCAGCTGCTGCTATATGTATACTTTTTCTTG
Delfullv3F GGTTCTGGATCAGGTGATATAAGACAAGCACATTGTAAC generating DV3
Delfullv3R ACCTGATCCAGAACCGTTGTTGGGTCTTGTACAATTAATTTC
V4delFnew GGCTCTGGTTCTGGGTGCAGAATAAAACAAATTATAAACATG generating DV4 with a
short linker
V4delRnew CCCAGAACCAGAGCCACAGTAGAAAAATTCTCCTCCAC
V5delFnew GGTAGCGGATCAGGCCCTGGAGGAGGAGATATGAG generating DV5 with a
short linker
V5delRnew GCCTGATCCGCTACCACCACCATCTCTTGTTAATAG
DelCD4blF GGTTCTGGATCAGGTAGTTTTAATTGTGGAGGAGAATTTTTC generating DCD4bl
DelCD4blR ACCTGATCCAGAACCGTGATTAAAGACTATTGTTTTATTCTC
V4FFL GGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCA GGCTCTGGTTCTGGG generating DV4 with a
linker of the same length
V4RFL CCGCCTGAACCGCCTCCACCACAGTAGAAAAATTCTCCTCCAC
V5FFL GGTGGAGGCGGTTCAGGTAGCGGATCAGGCCCTGGAGG generating DV5 with a
linker of the same length
V5RFL CTACCTGAACCGCCTCCACCACCACCATCTCTTGTTAATAG
JRFLCTfor CCTGGATGGAGTGGGAAAGAG generating DCT
JRFLCTrev CTCTTTCCCACTCCATCCAGG
doi:10.1371/journal.pone.0069789.t002
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20 min. If necessary, cells were permeabilized using 0.2% Triton
X-100 by incubation at RT for 30 min. Cells were then incubated
with IgG1 2G12 in 2% MPBS at 37uC for 1 h, washed two times
with PBS, and incubated with FITC conjugated to anti-human Fc
(Jackson ImmunoResearch) at 37uC for 1 h. Following washing
two times with PBS, cells were permeabilized using 0.2% Triton
X-100 by incubation at RT for 30 min, and incubated with
Hoechst 33258 (Invitrogen) at RT for 2 min to stain the nucleus.
Results
Effects of Variable Loop Deletions on Env Cell Surface
Display
We co-transfected 293T cells with pSVIII encoding JRFL
gp160 wild type (WT) or loop deletion mutants, and pcTAT
encoding HIV-1 Tat. 48 h post transfection, we did flow
cytometry to analyze cell surface display of Env gp160 WT and
the mutants using mAb 2G12 as a primary antibody and PE-anti-
human IgG, F(ab’)2 as a secondary antibody. We found that DV4,
DV5, and DlpDDV5 almost abolished Env cell surface display
(Fig. 1A, Table 3). Other loop deletion mutants also decreased
their cell surface display compared to the WT, including DV2,
DV2C, DV3, DV3C, DlpD, and DV1V2 (Fig. 1A, Table 3).
To determine whether CT deletion can rescue the defects in cell
surface display of Env loop deletion mutants, we deleted the CT in
JRFL gp160 WT and each loop deletion mutant, and generated
another panel of loop deletion mutants in combination with CT
deletion (DCT) (Table 3). A CD4 binding loop (DCD4bl) deletion
mutant in combination with DCT (DCD4blDCT) was included in
this panel of mutants and used as a control in the subsequent
pseudovirus assembly and entry assay. We found that DCT alone
significantly enhanced Env expression and cell surface display
(Fig. 1B), which is consistent with the result previously reported by
others. But deletion of CT did not rescue the defects of DV4 and
DV5 Envs in cell surface display (Fig. 1B, Table 3). The other loop
deletion mutants in combination with DCT had increased levels of
cell surface display compared to the corresponding loop deletion
alone mutants. The rescue was significant for DlpD mutant.
To determine whether decreased cell surface display of DV4
and DV5 Envs was caused by decreased transfection efficiency or
decreased Env expression, we measured the transfection efficiency
by IHC assay and determined the total DV4 and DV5 Env
expression in the whole cell lysates of transfected 293T cells by
capture ELISA using 2G12 as primary antibody. The percentages
of positive cells transfected with DV4 and DV5 Env plasmids, as
well as the rest of loop deletion mutant plasmids showed no
significant difference compared to the WT (Fig. 2A, and data not
Figure 1. Effects of various loop deletions on Env cell surface display. A: Flow cytometry of 293T cells co-transfected with various loop
deletion Env plasmids and pcTAT; B: Flow cytometry of 293 T cells co-transfected with various loop deletions and CT deletion plasmids and pcTAT.
Cells were incubated with HIV-1 mAb 2G12 and bound 2G12 measured by FITC-anti-human IgG, F(ab’)2.
doi:10.1371/journal.pone.0069789.g001
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shown), suggesting that loop deletion mutant plasmids can
transfect 293T cells as efficient as the WT plasmid. Capture
ELISA result showed that DV4 and DV5 Envs were well expressed
in the cells albeit to a decreased optical density (OD) at 405nm
(Fig. 2B), which may attribute to the loss of PNGS in the V4 and
V5, leading to decreased binding to 2G12. The rest of loop
deletion mutants expressed well in 293T cells and bound well to
2G12 (Fig. 2B).
Effects of Variable Loop Deletions on Virus Assembly and
Entry into Permissive Cells
The defects of DV4 and DV5 Envs in cell surface display led to
the failure in pseudovirus assembly and subsequent virus entry
(Fig. 2C, Table 3). Assembled pseudovirus was undetectable in the
culture supernatant of 293T cells co-transfected with pSVIII-DV4,
or -DV5, or -DlpDV5, and pcTAT and pNL4-3 backbone
plasmids. Interestingly, we found that DV1V2 also affected virus
assembly (Fig. 2C), and abolished virus entry (Table 3). More
interestingly, DlpD did not affect virus assembly (Fig. 2C), but the
assembled pseudovirus was not able to enter the permissive cells
(Table 3). Both DV2 and DV2C enhanced virus assembly, but
negatively affected virus entry. As expected, DV3 abolished virus
entry although the amount of assembled pseudovirus increased.
To our surprise, DV3C led to almost 20-fold increase in virus
assembly and 3-fold increase in virus entry compared to the WT
(Table 3). Deletion of CT in the WT Env significantly enhanced
pseudovirus assembly and subsequent entry into the cells, which is
consistent with the observation previously reported by others. But
deletion of CT did not rescue DV1V2 and DlpD viruses to enter
the cells although DlpDDCT had 5-fold increase in pseudovirus
assembly compared to DlpD alone (Table 3). Interestingly, we
found that DCT significantly enhanced assembly of DV2, DV3,
DV2C, and DV3C pseudoviruses (3-6-fold increases), and
enhanced the entry of DV2C and DV3C pseudoviruses into the
cells (Table 3). Combination of DCD4bl with DCT (DCD4blDCT)
also significantly enhanced pseudovirus assembly compared to the
WT (50-fold increase) although the assembled pseudoviruses could
not enter the cells, as expected (Table 3).
Deletion of V4 or V5 did not Cause gp120 Shedding
To investigate the possibility that DV4 and DV5 may enhance
gp120 shedding, resulting in lack of Env cell surface display, we
did a capture ELISA to detect soluble gp120 that may be present
in the culture supernatant of 293T cells co-transfected with
recombinant pSVIII plasmid encoding JRFL gp160 WT, or DV4,
or DV5, and pcTAT plasmid. IgG1 2G12 was used as a primary
antibody in the capture ELISA. The result showed that gp120 was
absent in the culture supernatant of 293T cells co-transfected with
the pSVIII gp160 DV4 or DV5 mutant plasmid, and pcTAT,
while gp120 was present in the culture supernatant of 293T cells
co-transfected with Env WT plasmid and pcTAT (data not
shown). This result indicates that undetectable DV4 and DV5 Envs
on cell surface may be attributed to the lack of Env cell surface
display, not to gp120 shedding.
Table 3. Effects of loop deletions with or without the CT deletion on JRFL gp160 cell surface display, virus assembly, and
subsequent virus entry.
ENV variants (JRFL)








WT 312 100 100 100
JRFLDV1V2 178 57 43 0
JRFLDV2 148 48 442 31
JRFLDV2C 159 51 258 35
JRFLDlpD 87 28 137 0
JRFLDV3 118 38 313 0
JRFLDV3C 101 32 1,828 343
JRFLDV4 9 3 1 NT
JRFLDV5 9 3 6 NT
JRFLDCT 457 147 2,259 6,375
JRFLDV1V2DCT 255 82 55 0
JRFLDV2DCT 217 70 1,733 91
JRFLDV2CDCT 437 140 1,095 253
JRFLDlpDDCT 428 137 612 0
JRFLDV3DCT 236 76 1,822 0
JRFLDV3CDCT 320 103 5,669 1,195
JRFLDV4DCT 6 2 1 NT
JRFLDV5DCT 9 3 2 NT
JRFLDlpDV5DCT 6 2 4 NT
JRFLDCD4blDCT 322 103 5,106 0
Cell surface displayed Env proteins were measured by flow cytometry. Mean values are shown and cell surface displayed Env proteins relative to the WT are calculated
as a percentage. The amount of assembled pseudovirus in culture supernatant was measured by capture ELISA. Three-fold serially diluted culture supernatants with a
starting volume of 50 ml were tested in luciferase assay. Relative pseudovirus entry was defined as a percentage of luminescence reading (response units, RU) of each
mutant virus relative to the WT when same amount of assembled pseudovirus was used. In this case, the same amount of pseudovirus gave OD405nm of 0.95 in the
capture ELISA (Fig. 2C). NT: not tested.
doi:10.1371/journal.pone.0069789.t003
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Figure 2. Effects of various loop deletions on total Env expression in 293T cells, Env binding to mAb 2G12, and pseudovirus
assembly. A: Immunostaining of 293T cells co-transfected with DV4 or DV5 Env plasmid and pcTAT with or without permeabilization prior to
staining with mAb 2G12; B: Binding of Env loop deletion mutant proteins in the whole cell lysates to 2G12 by capture ELISA; C: Titration of
pseudovirus in the culture supernatants by capture ELISA. The volume of each supernatant that contains the same amount of pseudovirus is
indicated with a flat line when OD405nm=0.95.
doi:10.1371/journal.pone.0069789.g002
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Effects of V4 and V5 Loop Deletions on Env Structural
Integrity
Since DV4 and DV5 Env proteins can be expressed in cells, but
cannot be displayed on cell surface, we examined the possible
conformational changes occurred to the Env proteins by
measuring their bindings to various mAbs by ELISA. We found
that DV4 and DV5 Env proteins lost the binding to CD4bs mAbs
b12 and VRC01, and CD4i mAbs X5 and 17b, but had increased
binding to gp41-specific mAbs m47 (N-trimer-specific)(unpub-
lished), 2F5 and 4E10 (MPER-specific) (Fig. 3A-G). The result
indicates that deletion of V4 or V5 may destroy Env structural
integrity, resulting in loss of the receptor and coreceptor binding
sites, and enhanced exposure of the N-trimer structure and the
MPER. Binding of glycan-specific mAb 2G12 to DV4 and DV5
Env proteins decreased, to some extent, which may be attributed
to the decreased number of PNGS in the Envs due to the deletion
of V4 and V5 (Fig. 3H).
Effects of V4 or V5 Replacement with a Flexible Linker of
the Same Length on Env Expression and Function
To investigate if V4 and V5 length, or amino acid composition,
or both contribute to the importance of V4 and V5 for Env cell
surface display and virus assembly, we generated two loop
replacement mutants, designated DV4fl and DV5fl, in which V4
or V5 was replaced with a flexible linker of the same length as the
original loop (Table 1). Flow cytometry and ELISA results showed
that there were no significant differences between DV4 and DV4fl,
or between DV5 and DV5fl in Env cell surface display (Fig. 4A and
4B), and in total Env protein expression in the cells (Fig. 4C and
4D), suggesting that amino acid composition of V4 and V5 may
play a more important role than the loop length in preserving Env
structural integrity and Env function.
Discussion
Engineering Env is one of approaches for HIV-1 vaccine
development. Understanding the importance of variable loops for
Env-mediated viral functions may help develop Env-based vaccine
immunogens and therapeutics against HIV-1 infection. Env CD4
binding loop and V3 are known to be involved in binding to the
receptor and coreceptor during virus entry. In this study, we found
that V1V2 and loop D were also critical for Env-mediated virus
entry into permissive cells. Therefore, V1V2 and loop D could be
key components of vaccine immunogens. Indeed, follow-up studies
on the recent RV144 trial demonstrate the importance of V1V2
loop for inducing protective antibodies against HIV-1 infection
[15]. Furthermore, V1V2 and loop D constitute partially the
neutralizing epitopes of bnmAbs PG9/16 and VRC01, respec-
tively. The critical roles of V1V2 and loop D in virus entry may
also be explored for developing entry inhibitors targeting these
regions. We did sequence alignment and found that six out of eight
amino acids in loop D were highly conserved in all HIV-1 subtype
viruses and the rest two relatively conserved (data not shown).
Targeting conserved loop D may be an alternative to current
approaches that target the CD4bs and/or glycans on Env trimer.
We further found that V4 and V5 were indispensable for Env
structural integrity, but deletion of V4 or V5 enhanced the
exposure of the N-trimer structure and the MPER of Env. Several
MPER-specific bnmAbs have been identified, including 2F5,
4E10, Z13e1 and 10e8 [16,17], and many MPER-based peptides
have been designed, but they failed to induce the same or similar
bnAbs. Our DV4 and DV5 Env proteins may be tested in animals
(rabbits or rhesus macaques) for inducing MPER-specific bnAbs.
Engineered Env with enhanced exposure of the MPER may help
induce MPER-specific nAbs in vivo.
Recently revealed cryo-EM structure of JRFL Env trimer
suggested the involvement of V1V2 and V3 in gp120 trimer
association [18]. Deletion of V1V2 may result in a decreased
association of gp120 with Env trimer. Therefore, viral escape from
nAbs by increased length and increased number of PNGS in
Figure 3. Effects of V4 and V5 loop deletions on Env structural integrity. 293T cells were co-transfected with recombinant pSVIII plasmid
encoding JRFL gp160 WT, or DV4, or DV5 mutant and pcTAT plasmid. 48h post transfection, the transfected cells were collected and lysed with cell
lysis buffer, and added to the ELISA plates coated with anti-HIV antibody D7324. Captured Env proteins were detected using gp120-specific CD4bs
mAbs VRC01, b12, or CD4i mAbs X5, 17b, or glycan-specific mAb 2G12, or gp41-specific mAbs 2F5, 4E10, m47 as primary antibody and HRP-anti
human IgG, F(ab’)2 as secondary antibody.
doi:10.1371/journal.pone.0069789.g003
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V1V2 region during chronic infection may come at the cost of
viral fitness. Loop D may be directly or indirectly involved in Env
interaction with the receptor CD4, so deletion of loop D abolished
virus entry. This notion is supported by the observation that amino
acid substitutions in loop D cause viral escape from CD4bs
bnmAb VRC01 [19]. Interestingly, we found that deletion of V2,
or V2 crown, or V3, or V3 crown significantly enhanced
pseudovirus assembly, especially when the CT was also deleted
(Table 3), but the effects of these deletions on pseudovirus entry
were different. Deletion of V2 or V2 crown negatively affected
psudovirus entry, while deletion of V3 abolished pseudovirus
entry. But to our surprise, we found that deletion of V3 crown
significantly enhanced pseudovirus entry, and this enhancement
was even more significant in the absence of CT. When the CT was
deleted, deletion of V2 crown also enhanced psudovirus entry.
Both V2 crown and V3 crown sequences were conserved, and V3
crown was very immunogenic and served as a target for
developing V3-specific nAbs and inhibitory peptides [20]. It was
postulated that V3 crown was critical for coreceptor binding based
on the observation that V3 crown structurally mimicked the b2-b3
loop in the CXC and CC chemokines [21]. But our study
indicated that V3 crown may not be involved in binding to the
coreceptor (either CCR5 or CXCR4). This is supported by two
observations. First, V3 crown was not involved in coreceptor
selectivity [21]. Second, antibodies targeting V3 stem showed
broad neutralizing activity [22].
Deletion of V4 or V5 did not lead to the failure in Env protein
expression, but significantly affect Env cell surface display, as well
as pseudovirus assembly and subsequent entry into the cells.
According to the crystal structure of gp120 core containing V4
and V5, deletion of V4 essentially removed a conserved glycan at
position 386 and half of the beta sheet-19, which may destroy the
CD4 binding site, while deletion of V5 removed half of the beta
sheet-24, which may in turn destabilize the neighboring CD4
binding loop. Nevertheless, expression of DV4 and DV5 Envs in
the cells was not significantly affected. Failure in exporting DV4
and DV5 Envs to cell surface suggested that V4 and V5 may be
involved in Env binding to host factors and/or matrix, which is
required for transportation machinery to display Envs on cell
surface. Loss of Env structural integrity caused by deletion of V4
Figure 4. Expression of Env mutants with V4 and V5 replaced with flexible linkers of the same lengths as the original loops in 293T
cells as measured by flow cytometry (A and B) and ELISA (C and D). 293T cells were co-transfected with recombinant pSVIII plasmid
encoding JRFL gp160 WT, or Env mutants with V4 (A and C) or V5 (B and D) replaced with a flexible linker of the same length as the original loop, and
pcTAT plasmid. 48h post transfection, the cells were detached and stained with 2G12 as primary antibody and PE-anti-human IgG, F(ab’)2 as
secondary antibody (A and B), or cells were lysed with cell lysis buffer and the expressed Envs in the cell lysate captured by anti-HIV antibody D7324
(5 mg/ml) coated on high binding ELISA plates and bound Env proteins measured by using 2G12 as primary antibody and HRP-anti human IgG,
F(ab’)2 as secondary antibody (C and D).
doi:10.1371/journal.pone.0069789.g004
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or V5 may be associated with the loss of binding of Env to the host
factors and/or matrix [23]. We found that replacement of V4 or
V5 with a flexible linker of the same length did not alleviate the
defects in Env cell surface display compared to the loop deletion
mutants (replaced with significantly shorter linkers), indicating that
V4 and V5 lengths may not be determining factors for virus
sensitivity to nAbs and disease progression. Instead, increased
numbers of PNGS in V4 and V5 along with the increased loop
lengths may play more important roles in viral escape from nAbs
and disease progression.
We tested the effect of DCT in combination with each loop
deletion on Env protein expression, Env cell surface display, and
pseudovirus assembly and subsequent entry. HIV-1 Env CT is
unusually long (150 amino acids) and highly conserved. It affects
Env cell surface display and subsequent virus assembly and entry
[23,24]. Interaction between matrix and CT is required for Env
incorporation into membrane and virus infectivity [25]. In this
study, we also observed that DCT alone led to increased Env
expression and Env cell surface display, and significantly enhanced
pseudovirus assembly and entry. But deletion of CT did not rescue
the defects of DV4 and DV5 Envs in cell surface display, and in
pseudovirus assembly and entry into the cells, suggesting that V4
and V5 deletion or replacement may be detrimental to Env
structure and function.
Conclusions
HIV-1 Env variable loops are indispensable for Env structural
integrity and Env-mediated virus entry. Deletion of V1V2, or V3,
or loop D abolished virus entry. Deletion of V4 or V5, or
replacement of V4 or V5 with flexible linkers of the same lengths
knocked out receptor and coreceptor binding sites in gp120, but
enhanced the exposure of the N-trimer structure and the MPER in
gp41. Deletion of V4 or V5 significantly affected Env cell surface
display, leading to the failure in virus assembly and subsequent
entry. Our findings suggest that, in addition to the CD4bl and V3,
other Env variable loops, such as V1V2, loop D, V4 and V5, may
be explored for development of vaccine immunogens and
therapeutics against HIV-1 infection.
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